Molecular dynamics of the COVID-19 pandemic in Espirito Santo (Brazil) and border States
- PMID: 35293562
- PMCID: PMC8916591
- DOI: 10.1590/S1678-9946202264024
Molecular dynamics of the COVID-19 pandemic in Espirito Santo (Brazil) and border States
Abstract
This study represents the first overview of the epidemiological dynamics of SARS-CoV-2 in Espirito Santo (ES) State, Brazil, filling in knowledge on this topic, observing data collected in the State, and aiming at understanding the epidemiological dynamics of the virus in ES, as well as its possible routes of transmission and dissemination. . Our results highlight that, so far, nine lineages have been identified with ES State. The B.1.1.33 lineage was the first with the highest occurrence in ES, remaining predominant until September 2020. The second predominant lineage was Gamma, representing 45% of the samples. The Delta lineage appears on the State scene, proving to be the next dominant lineage. This research allowed us to understand how the lineages advanced and were distributed in the State, which is important for future work, also making it possible to guide sanitary control measures. Data analyses were made through the GISAID database for ES State showed that the pandemic in the State has been evolving dynamically with lineage replacements over the months since the first notification.
Conflict of interest statement
The authors declare that the research was carried out without any conflict of interests.
Figures



References
-
- World Health Organization [cited 2022 Feb 21];WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-genera... .
-
- Johns Hopkins University & Medicine Coronavirus Resource Center. [cited 2022 Feb 21];COVID-19 dashboard. Available from: https://coronavirus.jhu.edu/map.html .
-
- Brasil. Ministério da Saúde [cited 2022 Feb 21];Coronavírus Brasil: painel Coronavírus. Available from: https://covid.saude.gov.br/
-
- Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19:305–306. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous